Maravai Lifesciences Holdings's total assets for Q3 2024 were $1.28B, a decrease of -11.70% from the previous quarter. MRVI total liabilities were $665.09M for the fiscal quarter, a -0.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.